| Model 1 | Model 2 |
---|
Prevalence rate ratio (95% CI) | Prevalence rate ratio (95% CI) |
---|
Year |
2009 | Ref. | Ref. |
2010 | 0.91 (0.85–0.97)** | 0.90 (0.85–0.96)** |
2011 | 0.80 (0.75–0.85)** | 0.80 (0.75–0.86)** |
2012 | 0.65 (0.60–0.69)** | 0.65 (0.61–0.70)** |
2013 | 0.68 (0.63–0.72)** | 0.68 (0.63–0.72)** |
P-value for trend | < 0.001 | < 0.001 |
Sex |
Female | Ref. | Ref. |
Male | 1.46 (1.40–1.52)** | 1.46 (1.40–1.52)** |
Age (years) |
55–64 | Ref. | Ref. |
65–74 | 1.12 (1.07–1.18)** | 1.12 (1.07–1.19)** |
75–84 | 1.38 (1.30–1.45)** | 1.38 (1.31–1.46)** |
85 and over | 1.76 (1.63–1.9)** | 1.12 (1.07–1.19)** |
P-value for trend | < 0.001 | < 0.001 |
Comorbidities |
Hypertension | 1.78 (1.69–1.88)** | 1.78 (1.69–1.88)** |
Nephropathy | 2.51 (2.33–2.70)** | 2.50 (2.33–2.69)** |
CVD | 2.29 (2.2–2.39)** | 2.29 (2.19–2.39)** |
Urbanization |
Urban | Ref. | Ref. |
Sub-urban | 1.47 (1.40–1.54)** | 1.47 (1.39–1.55)** |
Rural | 1.68 (1.58–1.78)** | 1.68 (1.56–1.82)** |
P-value for trend | < 0.001 | < 0.001 |
Median family income (NTD) |
585,000 and over | | Ref. |
533,000-584,999 | | 1.08 (1.02–1.14)** |
501,000-532,999 | | 1.03 (0.95–1.10) |
0–501,000 | | 1.05 (0.97–1.13) |
P-value for trend | | 0.434 |
Density of surgeons (no. per 105 population) |
20 and over | | Ref. |
10–19 | | 0.94 (0.87–1.02) |
5–9 | | 0.96 (0.87–1.07) |
0–4 | | 1.01 (0.91–1.13) |
P-value for trend | | 0.544 |
Density of internal medicine (no. per 105 population) |
40 and over | | Ref. |
20–39 | | 0.98 (0.90–1.06) |
10–19 | | 1.01 (0.90–1.12) |
0–9 | | 0.94 (0.85–1.06) |
P-value for trend | | 0.240 |
Density of family medicine (no. per 105 population) |
20 and over | | Ref. |
15–19 | | 0.95 (0.89–1.03) |
10–14 | | 0.92 (0.86–1.00)** |
0–9 | | 0.98 (0.91–1.06) |
P-value for trend | | 0.917 |
- ** P < 0.05
- NTD New Taiwan Dollar (1 USD ≈ 32 NTD)
- CVD cerebral vascular disease